Synthesis and effects on chloroquine susceptibility in Plasmodium falciparum of a series of new dihydroanthracene derivatives

Journal of Medicinal Chemistry

Volumn 45, Issue 15, 2002, Pages 3195-3209

  Alibert, Sandrine ^a   Santelli Rouvier, Christiane ^a   Pradines, Bruno ^b   Houdoin, Carole ^b   Parzy, Daniel ^b   Karolak Wojciechowska, Janina ^c   Barbe, Jacques ^a  

^a CNRS   (France)

^b SERVICE DE SANTÉ DES ARMÉES   (France)

^c LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

7 CHLORO 4 [[4 (DIETHYLAMINO)CYCLOHEXYL]AMINO]QUINOLINE; 9,10 DIHYDRO 9,10 ETHANOANTHRACENE DERIVATIVE; 9,10 DIHYDRO 9,10 ETHENOANTHRACENE DERIVATIVE; ANTHRACENE DERIVATIVE; CHLOROQUINE; DIHYDROANTHRACENE DERIVATIVE; MECAMYLAMINE; PROMETHAZINE; SN 9584; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; PHARMACOPHORE; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTHRACENES; ANTIMALARIALS; CHLOROQUINE; CHO CELLS; CRICETINAE; DRUG RESISTANCE, MULTIPLE; ERYTHROCYTES; MODELS, MOLECULAR; PLASMODIUM FALCIPARUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037130184     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm011046l     Document Type: Article

References (49)

1. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum
2. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil
3. Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum
4. Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum
5. Plasmodium chabaudi: Association of reversal of chloroquine resistance with increased accumulation of chloroquine in resistant parasite
6. Evaluation of resistant-reversal CDRI compound 87/209 and its possible mode of action in rodent experimental malaria
7. The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents
8. Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex vivo
9. Design of roof-shaped clathrate hosts. Inclusion properties and x-ray crystal structures of a free host and of inclusion compounds with 1-butanol and DMF
10. Electron paramagnetic resonance spectra of semiquinones. VII. Long-range electron paramagnetic resonance coupling in bridged anthracenes
11. PMR spectral studies of Diels Alder adducts: Anthracene crotonic acid, anthracene fumaric acid and α-naphthol-fumaric acid
12. Optically active ethanoanthracenes
13. Mixtures of optical antipodes. VI. 9,10-dihydro-9,10-ethanoanthracene derivatives
14. Unsaturated nitriles. IV. Adducts of dienes with fumaronitrile
15. Olefinic and acetylenic compounds. II. New routes to dibenzobarrelenes
16. Dihydro aromatic compounds in the Diels-Alder reaction. II. A model for veatchine synthesis
17. Oxidative decarboxylation of vicinal carboxylic acids as promoted by cuprous oxide quinoline
18. Cyano hydroborate anion as a selective reducing agent
19. Heteroaryl analogues of AMPA. Synthesis and quantitative structure activity relationships
20. Mild procedures for interconverting allylic oxygen functionality. Cyclisationinduced [3,3] sigmatropic rearrangement of allylic carbamates
21. Reversal of chloroquine resistance in falciparum malaria independent of calcium channels
22. In vitro reversal of chloroquine resistance in Plasmodium falciparum with dihydroethanoanthracene derivatives
23. In vitro increase of chloroquine accumulation by dihydroethano and ethenoanthracene derivatives in Plasmodium falciparum parasitized erythrocytes
24. Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum
25. Efflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance
26. Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors
27. Reversal of chloroquine resistance in Plasmodium falciparum by CDR 87/209 and analogues
28. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum
29. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum
30. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa
31. Molecular epidemiology of malaria in Yaounde, Cameroon. V. Analysis of the omega repetitive region of the Plasmodium falciparum CG2 gene and chloroquine resistance
32. Multidrug resistance and P-glycoprotein in parasitic protozoa
33. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole
34. Mutations in the Plasmodium falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
35. A molecular marker for chloroquine-resistant falciparum malaria
36. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum
37. The crystal and molecular structures of 9,10-dihydro-9,10-ethano and ethenoanthracenes
38. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America
39. Activities of various 4-aminoquinolines against infections with chloroquine-resistant strains of Plasmodium falciparum
40. Lack of cross-resistance to 4-amino-quinolines in chloroquine-resistant Plasmodium falciparum in vitro
41. The synthesis of 9,10-dihydro-9,-10-(11-aminoethano)anthracene
42. Synthesis and pharmacological properties of new 9,10-dihydro-9,10-ethanoanthracene derivatives
43. Synchronization of Plasmodium falciparum erythrocytic stages in culture